BCTX - NIO C3.ai leads the premarket losers' pack

FibroGen (FGEN) -25% on Q4 earnings release and after FDA to hold AdCom meet to review FibroGen, AstraZeneca's kidney drug.Comstock Mining (LODE) -19% after launching 4M-share public offering.Inseego (INSG) -16% on Q4 earnings release.RedHill Biopharma (RDHL) -12% after launching $10M capital raise.PLx Pharma (PLXP) -11%.C3.ai AI -10% on Q3 earnings release.Akers Biosciences (AKER) -9% on Q4 earnings release.Morphic Holding (MORF) -8% on announcement of a capital raise of $200M worth common stock.Chico's FAS (CHS) -8% on Q4 earnings release.BriaCell Therapeutics (BCTX) -7% after announces pricing of $25M public offering and nasdaq listing.3D Systems (DDD) -7% on Q4 earnings release.GrafTech International (EAF) -7% after announces secondary offering of common stock by existing stockholder.Lemonade (LMND) -7% on Q4 earnings release.Switch (SWCH) -7% on Q4 earnings release.Apollo Endosurgery (APEN) -6%.Koss (KOSS) -6%.Inovio Pharmaceuticals (INO) -6% on Q4 earnings release.Aemetis (AMTX) -6%.Xtant Medical Holdings (XTNT) -5%.Timber Pharmaceuticals (TMBR) -5%.International Game Technology (IGT) -5% on Q4 earnings release.NIO (NIO) -5% on Q4 earnings release

For further details see:

NIO, C3.ai leads the premarket losers' pack